Literature DB >> 8067999

Acetylation with succinimidyl acetate affects both the catalytic site and the regulation of the erythrocyte Ca2+ pump.

C Donnet1, A J Caride, H N Fernández, J P Rossi.   

Abstract

Acetylation of lysine residues of the erythrocyte Ca2+ pump using succinimidyl acetate (SA) led to its complete inactivation. In the absence of any of the major activators of the pump (namely calmodulin and acidic phospholipids), ATP fully protected the pump from inactivation by SA, with a K0.5 of 13 microM. This value is very close to the Km of the high-affinity site for ATP, thus suggesting that the residue(s) involved is(are) near or at the catalytic site of the Ca(2+)-ATPase. Furthermore, the presence of 500 microM ATP prevented the acetylation of about two residues per molecule of enzyme. Acetylation by SA also prevented the activation of the Ca2+ pump by calmodulin, acidic phospholipids or controlled trypsin proteolysis. This effect of SA treatment was not avoided by the presence of ATP in the preincubation medium, indicating a second set of modified residues. The fact that the three modes of activation were cancelled in a similar fashion by SA suggests that, although acting via different mechanisms, they share at least a common step in which SA-sensitive lysine residues may participate. Moreover, modification of the pump by SA plus ATP decreased the KCa when the activity was measured in both the absence and presence of calmodulin, suggesting that the residue(s) modified in this case is(are) involved directly in the regulation of the affinity for Ca2+.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8067999      PMCID: PMC1137200          DOI: 10.1042/bj3020133

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  Two classes of site for ATP in the Ca2+-ATPase from human red cell membranes.

Authors:  D E Richards; A F Rega; P J Garrahan
Journal:  Biochim Biophys Acta       Date:  1978-08-04

2.  Is the red cell calcium pump regulated by ATP?

Authors:  S Mualem; S J Karlish
Journal:  Nature       Date:  1979-01-18       Impact factor: 49.962

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  The maximal velocity and the calcium affinity of the red cell calcium pump may be regulated independently.

Authors:  A Enyedi; M Flura; B Sarkadi; G Gardos; E Carafoli
Journal:  J Biol Chem       Date:  1987-05-05       Impact factor: 5.157

5.  The role of the sites for ATP of the Ca2+ -ATPase from human red cell membranes during Ca2+ -phosphatase activity.

Authors:  A J Caride; A F Rega; P J Garrahan
Journal:  Biochim Biophys Acta       Date:  1982-08-12

6.  The effects of alkali metal ions on active Ca2+ transport in reconstituted ghosts from human red cells.

Authors:  R B Kratje; P J Garrahan; A F Rega
Journal:  Biochim Biophys Acta       Date:  1983-05-26

7.  Lack of tissue specificity of calmodulin: a rapid and high-yield purification method.

Authors:  S Kakiuchi; K Sobue; R Yamazaki; J Kambayashi; M Sakon; G Kosaki
Journal:  FEBS Lett       Date:  1981-04-20       Impact factor: 4.124

8.  Catalytic and regulatory ATP-binding sites of the red cell Ca2+ pump studied by irreversible modification with fluorescein isothiocyanate.

Authors:  S Muallem; S J Karlish
Journal:  J Biol Chem       Date:  1983-01-10       Impact factor: 5.157

9.  Reactivity of lysyl residues on the (Ca(2+)-Mg2+)-ATPase to 7-amino-4-methylcoumarin-3-acetic acid succinimidyl ester.

Authors:  H I Stefanova; A M Mata; J M East; M G Gore; A G Lee
Journal:  Biochemistry       Date:  1993-01-12       Impact factor: 3.162

10.  Calmodulin affinity chromatography yields a functional purified erythrocyte (Ca+ + Mg2+)-dependent adenosine triphosphatase.

Authors:  K Gietzen; M Tejcka; H U Wolf
Journal:  Biochem J       Date:  1980-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.